Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2024-11-01 4:09 pm Sale | 2024-09-30 | 13G | Tuya Inc. TUYA | New Enterprise Associates 14 L.P. | 114,084,633 22.600% | -4,934,640 (-4.15%) | Filing History |
2024-05-16 7:44 pm Unchanged | 2024-05-14 | 13D | Synlogic, Inc. SYBX | New Enterprise Associates 14 L.P. | 2,922,774 25.000% | 0 (Unchanged) | Filing History |
2024-05-15 7:21 pm Sale | 2024-05-13 | 13D | ZeroFox Holdings, Inc. ZFOX | New Enterprise Associates 14 L.P. | 0 0.000% | -18,068,513 (Position Closed) | Filing History |
2024-05-10 4:32 pm Unchanged | 2024-05-08 | 13D | NextNav Inc. NN | New Enterprise Associates 14 L.P. | 8,189,156 6.800% | 0 (Unchanged) | Filing History |
2024-05-06 7:46 pm Purchase | 2024-03-15 | 13D | Champions Oncology, Inc. CSBR | New Enterprise Associates 14 L.P. | 1,713,720 12.600% | 1,713,720 (New Position) | Filing History |
2024-04-02 8:38 pm Unchanged | 2024-04-01 | 13D | Adaptimmune Therapeutics plc ADAP | New Enterprise Associates 14 L.P. | 102,478,672 6.700% | 0 (Unchanged) | Filing History |
2023-10-13 4:17 pm Purchase | 2023-10-03 | 13D | Synlogic, Inc. SYBX | New Enterprise Associates 14 L.P. | 2,922,774 34.400% | 2,922,774 (New Position) | Filing History |
2023-03-30 5:13 pm Purchase | 2023-03-05 | 13D | Adaptimmune Therapeutics plc ADAP | New Enterprise Associates 14 L.P. | 102,478,672 10.300% | 3,556,804 (+3.60%) | Filing History |
2023-02-03 5:26 pm Sale | 2022-12-31 | 13G | Tuya Inc. TUYA | New Enterprise Associates 14 L.P. | 119,019,273 23.800% | -4,265,360 (-3.46%) | Filing History |
2023-01-09 4:32 pm Sale | 2023-01-03 | 13D | Oyster Point Pharma, Inc. OYST | New Enterprise Associates 14 L.P. | 0 0.000% | -5,925,287 (Position Closed) | Filing History |
2022-11-21 1:29 pm Unchanged | 2022-11-07 | 13D | Oyster Point Pharma, Inc. OYST | New Enterprise Associates 14 L.P. | 5,925,287 22.100% | 0 (Unchanged) | Filing History |
2022-08-12 5:17 pm Purchase | 2022-08-03 | 13D | ZeroFox Holdings, Inc. ZFOX | New Enterprise Associates 14 L.P. | 18,068,513 15.300% | 18,068,513 (New Position) | Filing History |
2022-05-24 5:11 pm Sale | 2022-05-23 | 13D | IMARA Inc. IMRA | New Enterprise Associates 14 L.P. | 0 0.000% | -480,212 (Position Closed) | Filing History |
2022-04-25 5:06 pm Sale | 2022-04-19 | 13D | IMARA Inc. IMRA | New Enterprise Associates 14 L.P. | 480,212 7.300% | -443,586 (-48.02%) | Filing History |
2022-02-15 5:13 pm Purchase | 2021-12-31 | 13G | Tuya Inc. TUYA | New Enterprise Associates 14 L.P. | 123,284,633 29.500% | 123,284,633 (New Position) | Filing History |
2022-01-10 1:13 pm Sale | 2021-12-27 | 13D | IMARA Inc. IMRA | New Enterprise Associates 14 L.P. | 923,798 14.100% | -79,701 (-7.94%) | Filing History |
2022-01-05 2:41 pm Sale | 2021-12-27 | 13D | Lumos Pharma, Inc. LUMO | New Enterprise Associates 14 L.P. | 0 0.000% | -524,030 (Position Closed) | Filing History |
2021-12-01 3:23 pm Purchase | 2021-10-28 | 13D | NextNav Inc. NN | New Enterprise Associates 14 L.P. | 8,189,156 8.600% | 8,189,156 (New Position) | Filing History |
2021-11-22 5:12 pm Purchase | 2021-11-14 | 13D | Casper Sleep Inc. CSPR | New Enterprise Associates 14 L.P. | 6,222,502 15.000% | 90 (+0.00%) | Filing History |
2021-03-10 9:40 pm Sale | 2020-08-05 | 13D | TRACON Pharmaceuticals, Inc. TCON | New Enterprise Associates 14 L.P. | 0 0.000% | -17,844 (Position Closed) | Filing History |